RAP 0.00% 20.5¢ resapp health limited

Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study, page-45

  1. 584 Posts.
    lightbulb Created with Sketch. 121
    thats just marketing fluff. the results speak for themselves. Lower respiratory tract disease, asthma/reactive airway disease (for children over 2 years of age) and primary upper respiratory tract disease are okay but not the game changer here.

    Pneumonia was the big one. Its back to the drawing board.

    87%PPA, 85%NPA for Pneumonia in Australian tests, but with a bigger sample 63%PPA and 62%NPA. That discrepancy is the issue.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.